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Snake venoms are rich sources of phospholipase A2 homo-
logues, both active calcium-binding Asp49 enzymes and
essentially inactive Lys49 proteins. They are responsible for
multiple pharmacological effects, some of which are depen-
dent on catalytic activity and others of which are not. Here,
the 2.4 AÊ X-ray crystal structure of an active Asp49
phospholipase A2 from the venom of the snake Bothrops
pirajai, re®ned to conventional and free R values of 20.1 and
25.5%, respectively, is reported. Unusually for phospholipases
A2, the dependence of the enzyme rate on the substrate
concentration is sigmoidal, implying cooperativity of substrate
binding. The unprecedented structural distortion seen for the
calcium-binding loop in the present structure may therefore
be indicative of a T-state enzyme. An explanation of the
interaction between the substrate-binding sites based on the
canonical phospholipase A2 dimer is dif®cult. However, an
alternative putative dimer interface identi®ed in the crystal
lattice brings together the calcium-binding loops of neigh-
bouring molecules, along with the C-terminal regions which
are disul®de bonded to those loops, thereby offering a possible
route of communication between active sites.
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PDB Reference: piratoxin III,
1gmz, r1gmzsf.
1. Introduction
Phospholipases A2 (PLA2s; E.C. 3.1.1.4) catalyse the speci®c
hydrolysis of the sn-2 acyl bond of sn-3 phospholipids,
producing lysophospholipids and fatty acids. The best under-
stood phospholipase A2 family encompasses enzymes from
mammals, insects and snakes. The ®rst structural determina-
tion of a member of this major family was that of the bovine
pancreatic enzyme (Dijkstra et al., 1978). Interest in the
enzymes from mammalian sources has focused recently on the
potential of their inhibitors as anti-in¯ammatory agents (e.g.
Schevitz et al., 1995). Crystal structures of PLA2s from snakes
(e.g. Keith et al., 1981) and insects (Scott et al., 1990) have
showed them to have an evolutionary relationship with the
bovine pancreatic enzyme. These enzymes share a functional
dependence on a Ca2+ ion, which binds to Asp49 (bovine
pancreatic enzyme numbering) and three backbone carbonyl
groups in the `calcium-binding loop', and a conserved catalytic
machinery centred on His48. Sequence and structural
comparisons (e.g. Scott & Sigler, 1994) have enabled the
division of the group into three classes: the highly homologous
classes I and II and a more varied class III. The structure of the
evolutionarily distinct human cytosolic enzyme has recently
been determined and represents the ®rst class IV PLA2
structure (Dessen et al., 1999).
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Snake venoms are remarkable for containing multiple PLA2
homologues (Pan et al., 1998; Tsai et al., 2000) with different
pharmacological properties, among them myotoxicity
(Gutierrez & Lomonte, 1995), oedema formation (Lloret &
Moreno, 1993), neurotoxicity (Verity, 1992) and platelet
aggregation (Gerrard et al., 1993). Many of these properties
are conferred by regions of the structure not involved in
catalysis, as illustrated by the myotoxicity of the minimally
catalytically active (e.g. Shimohigashi et al., 1995) subgroup of
PLA2 homologues which possess a lysine at position 49
(Maraganore et al., 1984). Numerous attempts have been
made to correlate their sequence and structural characteristics
with their pharmacological properties (e.g. Ward et al., 1998).
Three PLA2 homologues derived from the venom of the
snake Bothrops pirajai have been the subjects of biochemical
(Toyama et al., 1999, 2000; Soares et al., 2001) and crystallo-
graphic studies (Lee et al., 2001). Piratoxins I and II, with near-
identical sequences (Toyama et al., 2000), are essentially
inactive Lys49 PLA2 homologues, while piratoxin III is an
active Asp49 PLA2 enzyme (Mancuso et al., 1995; Soares et al.,
2001) identical to the separately sequenced MP-III 4R
(Toyama et al., 1999).
Here, we present a crystal structure of piratoxin III. In
common with several other PLA2s (Burke et al., 1995; Beghini
et al., 2000), piratoxin III exhibits a cooperative relationship
between enzyme rate and substrate concentration. The
structure contains a dramatically distorted Ca2+-binding loop
and may represent an inactive T-state of the enzyme.
2. Materials and methods
2.1. Protein purification
PrTX-III was isolated and puri®ed from the whole venom of
B. pirajai by reverse-phase and cation-exchange HPLC. 20 mg
of whole venom were dissolved in 250 ml 0.1%(v/v) tri¯uoro-
acetic acid (solvent A). The resulting sample was centrifuged
and the supernatant was applied onto a 0.78  30 cm
-Bondapack C-18 column (Waters 991 ± PDA system).
Puri®cation of the venom was performed with a linear
gradient of 0±66%(v/v) acetonitrile in 0.1%(v/v) tri¯uoro-
acetic acid (solvent B) at a ¯ow rate of 2.0 ml minÿ1 and was
monitored at 280 nm. The MPIII fraction was lyophilized and
dissolved in 0.05 M ammonium bicarbonate pH 7.4, centri-
fuged and applied onto a 0.39  7.8 cm protein pack SP 5PW
cation-exchange column previously equilibrated with the same
buffer. Elution of PrTX-III was performed using a linear
gradient of ammonium bicarbonate from 0.05 to 1.0 M at pH
7.4. The chromatographic run was performed at ¯ow rate of
1.0 ml minÿ1 and was monitored at 280 nm. The puri®ed
sample was lyophilized and used for crystallization trials.
2.2. Crystallization and collection of X-ray diffraction data
Preliminary screening for crystallization conditions was
performed using a sparse-matrix screen at 291 K (Crystal
Screens I and II, Hampton Research). Lyophilized PrTX-III
was initially dissolved in water to a concentration of
10 mg mlÿ1 and used in the screening procedure. Small crys-
tals were found using solution 40 of the Crystal Screen I kit
(20% 2-propanol, 20% PEG 4000, 0.1 M sodium citrate pH
5.6). These conditions were then re®ned. Plate-like crystals
measuring 0.1  0.1  0.02 mm were grown at 291 K using the
hanging-drop vapour-diffusion method by mixing equal
volumes (1 ml + 1 ml) of a protein solution concentrated to
5 mg mlÿ1 with a reservoir solution consisting of 18%
2-propanol, 21% PEG 4000 and 0.1 M sodium citrate pH 5.3.
Crystals appeared in 10±15 d.
X-ray diffraction data were collected at the Protein
Crystallography beamline (Polikarpov et al., 1998) at the
LaboratoÂ rio Nacional de Luz SõÂncrotron (LNLS), Campinas,
Brazil. The images were recorded on a MAR345 image plate
using synchrotron radiation at an optimal wavelength of
1.535 AÊ (Polikarpov et al., 1997). The images were processed
and scaled with the DENZO and SCALEPACK programs
(Otwinowski, 1993), yielding the statistics in Table 1. Calcu-
lations of Matthews coef®cients (Matthews, 1968) suggested
the presence of two molecules per asymmetric unit
(VM = 2.84 AÊ
3 Daÿ1).
2.3. Computational crystallographic methods
MOLREP (Vagin & Teplyakov, 1997) was used to solve the
structure by molecular replacement. Crystallographic re®ne-
ment then proceeded with alternating rounds of computa-
tional re®nement and map calculation with CNS (BruÈ nger et
al., 1998) and manual model inspection and modi®cation with
O (Jones et al., 1991). A free R factor (BruÈ nger, 1992),
calculated from 5% of re¯ections set aside at the outset, was
used to monitor the progress of re®nement, to aid in the
choice of B-factor re®nement protocol at different stages of
re®nement and to help choose appropriate schemes for
handling non-crystallographic symmetry (Kleywegt &
BruÈ nger, 1996). In this way, the initial anisotropic overall B
factor was replaced successively with per-residue B factors,
separate per-residue B factors for main- and side-chain atoms
and, ®nally, restrained individual atomic B factors. Initial
re®nement was carried out using a strict NCS relationship
between the two monomers in the asymmetric unit. When
re®nement under this scheme could proceed no further, it was
replaced by a system of strong restraints on both coordinates
and B factors, from which NCS-breaking residues were
progressively exempted based on examination of maps.
Table 1
Crystal and data statistics.
Values in parentheses are for the highest resolution shell.
Space group C2
Unit-cell parameters (AÊ , ) a = 61.0, b = 100.9,
c = 48.3,  = 123.8
Resolution (AÊ ) 14.7±2.4 (2.5±2.4)
Completeness (%) 85.9 (89.6)
hI/(I)i 7.3 (2.1)
Average redundancy 2.88 (2.0)
Rmerge (%) 11.4 (26.4)
The model bias present in the initial molecular-replacement
solution was tackled using A-weighted electron-density maps
(Read, 1986), maximum-likelihood re®nement targets (Pannu
& Read, 1996), torsion-angle simulated annealing (Rice &
BruÈ nger, 1994; Adams et al., 1997) and solvent ¯attening
(Cowtan & Zhang, 1999). All data in the 15 to 2.4 AÊ resolution
range were used throughout, without the application of  or
amplitude-based cutoffs. A variety of stereochemical
(Laskowski et al., 1993) and other analyses (Jones et al., 1991;
Kleywegt & Jones, 1996) were periodically performed in order
to locate possible model errors. Coordinate, topology and
parameter ®les for 2-propanol were obtained from the
HIC-UP database (Kleywegt & Jones, 1998). When the free R
value reached 27%, waters were added in three cycles using
programs from the CCP4 package (Collaborative Computa-
tional Project, Number 4, 1994). Water molecules were placed
into 3 peaks in A-weighted Fo ÿ Fc maps when they were
within a suitable hydrogen-bonding distance of the existing
model. After re®nement, water molecules whose positions
were not supported by electron density at 1 contouring in a
A-weighted 2Fo ÿ Fc map were deleted.
2.4. Structure and sequence analysis
Structural comparisons were made using LSQMAN
(Kleywegt, 1999), MAP (Lu, 2000) and DALI (Holm &
Sander, 1998). STRIDE (Frishman & Argos, 1995) was used
for the de®nition of secondary-structure elements. Programs
from the PHYLIP package (Felsenstein, 1989) were used to
construct a neighbour-joining tree representation of structural
similarities from MAP-derived data. From an initial tree
containing all class I and class II PLA2 crystal structures
(except mutants and chemically modi®ed proteins), very
similar pairs of structures were identi®ed and the lower
resolution structure deleted. BOBSCRIPT (Esnouf, 1997) and
MOLSCRIPT2 (Kraulis, 1991) were used to produce struc-
tural ®gures, while ALSCRIPT (Barton, 1993) was used to
format alignments. Xmgrace (http://plasma-gate.weizmann.ac.il/
Grace/) was used to plot graphs.
2.5. Enzyme assay
PLA2 activity was measured using a previously described
assay (Cho & KeÂzdy, 1991; Holzer & Mackessy, 1996) modi®ed
for 96-well plates. The standard assay mixture contained
200 ml buffer (10 mM Tris±HCl, 10 mM CaCl2, 100 mM NaCl
pH 8.0), 20 ml of the synthetic substrate 4-nitro-3-(octanoyl-
oxy) benzoic acid, 20 ml water and 20 ml PLA2 in a ®nal
volume of 260 ml. After addition of PLA2 (20 mg), the mixture
was incubated for up to 40 min at 310 K, with the absorbance
being read at 10 min intervals. The enzyme activity, expressed
as the initial velocity of the reaction (Vo), was calculated based
on the increase in absorbance after 20 min for various
substrate concentrations. All assays were performed in tripli-
cate and the absorbances at 425 nm were measured using a
SpectraMax 340 multiwell plate reader (Molecular Devices,
Sunnyvale, CA, USA).
3. Results and discussion
3.1. Structure solution and refinement
Suitable structures to use in molecular replacement were
determined using the FFAS program (Rychlewski et al., 2000).
For each, a model was built for the piratoxin III sequence
(Toyama et al., 1999) using the MODELLER program (Sali &
Blundell, 1993). These ®ve models were superimposed and
used as input to MOLREP (Vagin & Teplyakov, 1997) by
applying the NMR option. The use of multiple independent
models can improve molecular-replacement results, particu-
larly in dif®cult cases (e.g. Leahy et al., 1992). MOLREP
straightforwardly solved the molecular-replacement problem
automatically. The correct rotation solution was positioned
®rst with a rotation function/ value of 9.55, compared with
the next best scoring solution of 6.01. Using this rotation, the
correct translation solution for the ®rst molecule in the
asymmetric unit had a correlation coef®cient of 0.236 and an R
factor of 54%. Placing of the second molecule resulted in a
correlation coef®cient of 0.360 and an R factor of 50%.
In order to determine which of the ®ve models was the best
basis for further re®nement, the multiple MR solution was
`dissociated' into its ®ve component models and each of these
was subjected to rigid-body re®nement followed by multiple
torsion-angle simulated annealing in CNS (BruÈ nger et al.,
1998). Ten different annealed structures were generated for
each starting model. Comparison of these results clearly
showed re®ned 1cl5-based models to be the best bases for
further re®nement (Table 2). Table 2 also shows the effec-
tiveness of torsion-angle simulated annealing in combination
with a maximum-likelihood re®nement target, cross-validation
(Rice & BruÈ nger, 1994; Adams et al., 1997) and strict NCS. A
dramatic 12% reduction in Rfree compared with the rigid-body
re®ned model was achieved in a single step.
Solvent ¯attening was also employed and yielded signi®cant
improvements in map quality and interpretability. As re®ne-
ment progressed, two regions of difference map density
located in the binding sites of each monomer were convin-
cingly modelled as 2-propanol molecules. 135 water molecules
could be located during the ®nal stages of re®nement.
In the ®nal model 44 of the 121 residues were exempted
from the strong NCS restraints otherwise applied: residues
1±3, 10, 17, 19, 21±24, 27±33, 42, 45, 55±58, 60±61, 63, 66, 77±81,
Acta Cryst. (2003). D59, 255±262 Rigden et al.  Piratoxin III 257
research papers
Table 2







re®nement Maximum Minimum Mean
1aok 0.510 0.483 0.458 0.469
1b4w 0.509 0.439 0.415 0.431
1cl5 0.507 0.423 0.386 0.410
1clp 0.515 0.454 0.426 0.441
1vip 0.503 0.483 0.439 0.453
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106, 109, 111±114 and 116±120. With eight
exceptions (residues 27±29, 45, 63, 66 and
80±81), these are involved in crystal
contacts or are neighbours of crystal
contacts.
During re®nement, several mismatches
between side chains corresponding to
published piratoxin III sequences and
electron density became apparent. The






His110!Tyr and Pro113!Ser. This
unusually high error rate for the protein
primary sequence was con®rmed by the
sequencers (Marcos Toyama, personal
communication). Information from homo-
logous sequences was used to help deter-
mine the most likely correct residues at
each position. A simulated-annealing omit
map density for Met108±Tyr110 in subunit
A of the ®nal model is shown in Fig. 1. The presence of a small
number of further sequence errors, particularly for residues
with isosteric alternatives, cannot be ruled out. In the C-
terminal region, the ®nal model suggests the presence of an
additional residue not present in the piratoxin III sequence.
With the following residue numbers adjusted accordingly, this
would lie between Lys117 and Ala119. The distance between
Lys117 C and Ala119 N in subunit B, which would be cova-
lently linked in the absence of an extra residue, is 4.71 AÊ .
PLA2 sequences in general show signi®cant length variation in
the C-terminal region. Database searches reveal the existence
of many PLA2 homologues with an extra residue at exactly
this position (the most similar from Agkistrodon halys pallas
with SWISS-PROT accession No. O42187), which is usually
serine or threonine.
3.2. Description of the final model
The data in Tables 1 and 3 show a well re®ned structure with
excellent stereochemistry. The structure is, for the most part,
well de®ned by electron density (Fig. 2). The only signi®cant
regions of poorer de®nition, as seen in elevated B factors and
poorer real-space correlation coef®cients (Fig. 2), are the loop
from residues 75 to 80 and the C-terminal region from position
110 onwards. Disorder prohibited the modelling of residue
Asn78 in either subunit, the inferred residue 118 (see above)
in either subunit and Ala119 in subunit A. In a Ramachandran
plot (Laskowski et al., 1993), 86.7% of residues are located in
the most favoured areas, none in disallowed areas and just two
in generously allowed areas. These, Leu114 in subunit B and
Lys116 in subunit A, are reasonably well de®ned by density,
albeit located in the C-terminal region with higher B factors
(Fig. 2).
The ®nal model contains the now familiar three major
helices in an almost parallel arrangement and the -wing. A
fourth shorter helix, sometimes de®ned in other crystal
structures (e.g. Fig. 3), is not identi®ed as such by STRIDE
(Frishman & Argos, 1995) in the present structure owing to
the disruptive effect of the cis-peptide bond preceding Pro19.
Despite its proximity to the substrate-binding site, the varia-
bility in sequence and peptide-bond nature at position 19
seems to have no functional consequences.
The two 2-propanol molecules in the ®nal model, one bound
to each subunit, are well de®ned by density, with real-space
Figure 1
Stereo ®gure illustrating simulated-annealing omit map density for residues 108±110 in subunit
A. Density in a A-weighted 2Fo ÿ Fc map, calculated after simulated annealing with the three
residues omitted, is contoured at 1.
Figure 2
(a) Per-residue B factors (AÊ 2) and (b) real-space correlation coef®cient
for the ®nal model. Solid lines are used for subunit A and dotted lines for
subunit B.
correlation coef®cients of 0.83 and 0.80 and B factors of 48.1
and 48.7 AÊ 2, respectively. The trigonal pyramidal shape of
2-propanol means that its exact orientation in the density, if a
single orientation indeed exists, cannot be determined; in no
orientation is the O atom capable of hydrogen bonding to the
protein. This situation is reminiscent of the cottonmouth
snake venom K49 PLA2 crystal structure in which density, also
in the PLA2 binding pocket, was interpreted as dioxane which,
like the 2-propanol here, was present in the crystallization
conditions (Holland et al., 1990). In line with the absence of
calcium in the crystallization conditions, no Ca2+ ions were
assigned in the ®nal model. The program WASP (Nayal & Di
Cera, 1996) was used to con®rm the absence of possible
calcium ions among those assigned as water.
Despite nearly a third of residues disobeying the NCS
relationship between subunits A and B, C differences for
corresponding residues in the superposed subunits are less
than 1 AÊ , with the sole exception of the C-terminal region
from residues 117±121 (Fig. 4).
3.3. Structural comparisons
For comparison of the model with other structures, the
consensus PLA2 numbering scheme introduced by Renetseder
et al. (1985) will be used. Its relationship to piratoxin III
numbering may be seen in Fig. 3.
Examination of the crystal lattice shows that a putative
dimer can be identi®ed with an interface resembling that
observed in previous crystal structures involving the -wing
(e.g. da Silva Giotto et al., 1998; Lee et al., 2001; see Fig. 5).
However, an alternative dimer structure can be identi®ed with
similarly favourable properties (Fig. 5). This alternative
interface involves the C-terminal regions, the Ca2+-binding
loops and the two helices 2, which lie nearly parallel and
whose contacts centre on Gly53. The carboxyl group of Gly33
on the radically reorganized Ca2+-binding loop (see below)
forms a hydrogen bond across the interface with Ser56 of the
alternate subunit. Recent work shows that simple interface
surface area is by far the most important consideration in
predicting physiological dimers among crystal contacts
between monomers (Valdar & Thornton, 2001). Calculations
show that the isolated subunit B loses 516 AÊ 2 on formation of
the conventional interface and 510 AÊ 2 on formation of the
alternative interface. Similarly, shape-complementarity
analysis (Lawrence & Colman, 1993) reveals near-identical
values of 0.51 and 0.53, respectively. The B factors of the -
wing offer little help in choosing between possible dimers. In
the conventional dimer structures, the B factors of the -wing
are depressed (e.g. da Silva Giotto et al., 1998), in contrast to
their elevation relative to the remainder of the structure in the
monomeric enzyme structure (Arni et al., 1999). In the present
structure, the -wing B factors, which are 31.9 and 37.4 in
subunits A and B, respectively, are close to the overall B factor
of 32.7. The general existence of
¯exibility of oligomerization in
the PLA2 family is illustrated by
the trimer observed in crystals of
Indian cobra phospholipase A2
(Fremont et al., 1993).
The result of a systematic
subunit comparison of the
present structure with other
PLA2s is shown in Fig. 6. Three
main branches are evident in the
tree. Two correspond to class I
and class II PLA2 enzymes (top
and centre, respectively, in Fig.
6), while the third contains the
vipoxin complex (PDB code
1aok; Perbandt et al., 1997) and
its isolated inhibitor chain (PDB
code 1vpi; Devedjiev et al., 1997).
The present structure is clearly
positioned in the class II PLA2
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Figure 3
Alignment of piratoxin III with 1qll and 1vip. Piratoxin III numbering, as present in the PDB ®le, is shown
above the alignment and the consensus numbering scheme introduced by Renetseder et al. (1985) is shown
below the alignment. Secondary-structure elements were de®ned with STRIDE (Frishman & Argos, 1995).
Conserved residues are shaded, residues whose main chain is involved in calcium binding are boxed and
position 49, either Lys or Asp in the different PLA2 classes, is in bold.
Table 3
Re®nement statistics.
Values in parentheses are for the highest resolution shell.
No. of non-H protein atoms 1887
No. of non-H 2-propanol atoms 8
No. of non-H solvent atoms 135
Resolution range (AÊ ) 14.7±2.4 (2.5±2.4)
No. of re¯ections 8166 (1046)
R (%) 20.1 (30.1)
Rfree (%) 25.5 (36.5)









R.m.s. deviation from ideal values
Bond lengths (AÊ ) 0.007
Bond angles () 1.4
research papers
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branch of the tree but, compared with the structures of that
branch, is structurally divergent. Examination of the super-
posed class II structures reveals the main differences to lie in
two regions of the chain; the Ca2+-binding loop around residue
30 and the C-terminal region around residue 125. For the
purposes of detailed comparisons, both chains of the present
structure were compared with the structure of K49 piratoxin II
(PDB code 1qll; Lee et al., 2001) and the most similar D49
enzyme structure, that of the enzyme from Vipera russelli
russelli (PDB code 1vip; Carredano et al., 1998). The
comparison is illustrated in Figs. 4 and 7.
While a degree of structural variability in both the
Ca2+-binding loop (in the absence of Ca2+) and the C-terminal
region is commonly noted in PLA2 structures, the structural
variation exhibited in the present structure is of a different
order (Figs. 4 and 7). The binding of Ca2+, required for
phospholipase activity in D49 PLA2s (Scott & Sigler, 1994),
involves the main-chain carbonyl groups of residues 28, 30 and
32. In the Ca2+-bound human enzyme (PDB code 1kvo; Cha et
al., 1996), the distance between Ca2+ and Gly30 O is 2.3 AÊ .
From this same essentially invariant Ca2+ position, Gly30 O in
1vip (D49, calcium-free) is at a distance of 4.2 AÊ ; Gly30 O in
Figure 5
Possible dimer interfaces identi®ed from analysis of crystal contacts. The
`conventional' dimer comprises the central coloured subunit and the
dotted subunit (upper right). The `alternative' dimer contains the central
subunit and the white subunit (lower left). Helices, strands and coil of the
central subunit are coloured blue, green and yellow, respectively. Thick
dotted lines indicate parts of the structure for which density did not
permit location of the model. The calcium-binding loop and C-terminal
tail are drawn in broader coil and labelled C and T, respectively. The
2-propanol molecule occupying the hydrophobic part of the substrate-
binding site is drawn and labelled P. Asp49 residues are drawn and
labelled, as are two disul®de bonds linking the calcium-binding loop and
the C-terminal tail, Cys27±Cys125 (labelled 1) and Cys50±Cys133
(labelled 2), mentioned in the text. The inter-subunit hydrogen bonds
between Gly33±Ser560 and Gly330±Ser56 are represented by narrow
dotted lines.
Figure 6
Neighbour-joining tree representation of structural relationships among
PLA2s. Distances between structures are calculated from their structural
similarities as quantitated with MAP (Lu, 2000).
Figure 4
C displacements along the chain for subunit A of the present structure
(dotted line), 1qll (solid line) and 1vip (dashed line) superimposed on
subunit B.
1qll (K49) is 4.0 AÊ away. The same measurement in the
present structure yields 8.6 AÊ in subunit A and 8.3 AÊ in
subunit B (see also Fig. 7). Clearly, the distortion of the
calcium-binding loop in the present structure goes well
beyond that expected to arise from the simple absence of
calcium. The extreme diversion taken by the main chain at
residues 30±31 seems to be associated with a change in the
backbone dihedral angles of Cys29. In previous crystal struc-
tures, it occupies the  area of the Ramachandran plot, with
typical ',  values of aroundÿ80,ÿ120. In the new piratoxin
III structure it is shifted to the  area, with ',  angles of ÿ52,
ÿ57. This change is clearly de®ned by the electron-density
maps (Fig. 2).
3.4. Functional aspects
Piratoxin III is known to possess the PLA2 activity expected
of a D49 member of the family (Soares et al., 2001). Inter-
estingly, using the synthetic non-micellar substrate 4-nitro-
3-(octanoyloxy) benzoic acid (Holzer & Mackessy, 1996), the
dependence of activity on substrate concentration is markedly
sigmoidal (Fig. 8), with an S0.5 value of around 28.4 mM and a
Hill coef®cient of 3.7. Classical Michaelis±Menten behaviour
is more commonly reported for PLA2s, but a number of other
reports of sigmoidal rate substrate behaviour have appeared
(Burke et al., 1995; Beghini et al., 2000).
One common explanation for this behaviour would be the
existence of both active and inactive structural conformations,
the transition between which is in¯uenced by substrate. Since
the crystallized form would be unable to bind calcium and
hence be catalytically inactive, it is tempting to regard it as an
inactive T-state form and suppose that an active R-state can be
induced by substrate binding. The R-state would more closely
resemble existing crystal structures for other PLA2 enzymes,
with the canonical Ca2+-binding loop structure (Lee et al.,
2001). Intriguingly, a dimer interface of the `alternative' type
observed in the crystal lattice (Fig. 5) would offer plausible
routes of communication between active sites. The binding of
phospholipid substrate to one site, with the phospho group
interacting with bound Ca2+, could readily in¯uence the
conformation of the Ca2+-binding loop of that subunit.
Through the disul®de bridge between Cys27 and Cys125, this
signal could be transmitted to the C-terminal portion. The
disul®de bridge between Cys50, the neighbour of the calcium-
binding Asp49, and Cys133 offers an additional route for
communication of a signal from substrate-binding site to the
C-terminal tail. Both the Ca2+-binding loop and C-terminal
region contribute to the `alternative' dimer interface (Fig. 5) so
that conformational changes could readily be transmitted to
the alternate dimer, conferring cooperative substrate on the
enzyme. In the `conventional' dimer structure, substrate
binding occurs distant to the interface (Fig. 5), so that
communication between subunits is not readily explained. The
frustrating dif®culty in determining the biologically relevant
dimer interface, much as functional data must favour the
`alternative' type, should encourage further study of PLA2s
that show sigmoidal dependence of rate on substrate
concentration, particularly the determination of holo- and
apo-enzyme structures of the same enzyme.
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Figure 7
Schematic representation of the piratoxin III ®nal model. Helices, strands
and coil are coloured blue, green and yellow, respectively. In regions of
signi®cant structural difference, the superposed structures of 1qll
(magenta) and 1vip (cyan) are drawn. The C atoms of Gly30 in the
structures are drawn as spheres in the same colours. Catalytic residues
(white bonds) and fatty-acid binding residues (Lee et al., 2001; brown
bonds) are shown in ball-and-stick representation, along with Lys122 in
the present structure and in 1qll. The modelled position of 2-propanol in
the present structure is drawn in a fatter ball-and-stick representation.
Dotted lines in the backbone trace mark regions not de®ned by electron
density. Dotted lines between catalytic residues indicated hydrogen
bonds.
Figure 8
The dependence of initial PLA2 rate (Vo) on substrate concentration (S).
Measurements were made in triplicate. The data were ®tted to the Hill
equation, yielding a Hill constant of 3.7 and S0.5 of 28.4 mM. The error
bars mark standard deviations.
research papers
262 Rigden et al.  Piratoxin III Acta Cryst. (2003). D59, 255±262
References
Adams, P. D., Pannu, N. S., Read, R. J. & BruÈ nger, A T. (1997). Proc.
Natl Acad. Sci. USA, 94, 5018±5023.
Arni, R. K., Fontes, M. R., Barberato, C., Gutierrez, J. M., Diaz, C. &
Ward, R. J. (1999). Arch. Biochem. Biophys. 366, 177±182.
Barton, G. J. (1993). Protein Eng. 6, 37±40.
Beghini, D. G., Toyama, M. H., Hyslop, S., Sodek, L. C., Novello, J. C.
& Marangoni, S. (2000). J. Protein Chem. 19, 679±684.
BruÈ nger, A. T. (1992). Nature (London), 355, 472±474.
BruÈ nger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P.,
Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M.,
Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T. & Warren, G. L.
(1998). Acta Cryst. D54, 905±921.
Burke, J. R., Witmer, M. R., Tredup, J., Micanovic, R., Gregor, K. R.,
Lahiri, J., Tramposch, K. M. & Villafranca, J. J. (1995).
Biochemistry, 34, 15165±15174.
Carredano, E., Westerlund, B., Persson, B., Saarinen, M., Ramas-
wamy, S., Eaker, D. & Eklund, H. (1998). Toxicon, 36, 75±92.
Cha, S. S., Lee, D., Adams, J., Kurdyla, J. T., Jones, C. S., Marshall,
L. A., Bolognese, B., Abdel-Meguid, S. S. & Oh, B. H. (1996). J.
Med. Chem. 39, 3878±3881.
Cho, W. & KeÂzdy, F. J. (1991). Methods Enzymol. 197, 75±79.
Collaborative Computational Project, Number 4 (1994). Acta Cryst.
D50, 760±763.
Cowtan, K. D. & Zhang, K. Y. (1999). Prog. Biophys. Mol. Biol. 72,
245±270.
Dessen, A., Tang, J., Schmidt, H., Stahl, M., Clark, J. D., Seehra, J. &
Somers, W. S. (1999). Cell, 97, 349±360.
Devedjiev, Y., Popov, A., Atanasov, B. & Bartunik, H. D. (1997). J.
Mol. Biol. 266, 160±172.
Dijkstra, B. W., Drenth, J., Kalk, K. & Vandermaalen, P. J. (1978). J.
Mol. Biol. 124, 53±60.
Esnouf, R. M. (1997). J. Mol. Graph. 15, 132±134.
Felsenstein, J. (1989). Cladistics, 5, 164±166.
Fremont, D. H., Anderson, D. H., Wilson, I. A., Dennis, E. A. &
Xuong, N. H. (1993). Proc. Natl Acad. Sci. USA, 90, 342±346.
Frishman, D. & Argos, P. (1995). Proteins, 23, 566±579.
Gerrard, J. M., Robinson, P., Narvey, M. & McNicol, A. (1993).
Biochem. Cell Biol. 71, 432±439.
Gutierrez, J. M. & Lomonte, B. (1995). Toxicon, 33, 1405±1424.
Holland, D. R., Clancy, L. L., Muchmore, S. W., Ryde, T. J., Einspahr,
H. M., Finzel, B. C., Heinrikson, R. L. & Watenpaugh, K. D. (1990).
J. Biol. Chem. 265, 17649±17656.
Holm, L. & Sander, C. (1998). Nucleic Acids Res. 26, 316±319.
Holzer, M. & Mackessy, S. P. (1996). Toxicon, 34, 1149±1155.
Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. (1991). Acta
Cryst. A47, 110±119.
Keith, C., Feldman, D. S., Deganello, S., Glick, J., Ward, K. B., Jones,
E. O. & Sigler, P. B. (1981). J. Biol. Chem. 256. 8602±8607.
Kleywegt, G. J. (1999). Acta Cryst. D55, 1878±1884.
Kleywegt, G. J. & BruÈ nger, A. T. (1996). Structure, 4, 897±904.
Kleywegt, G. J. & Jones, T. A. (1996). Acta Cryst. D52, 829±832.
Kleywegt, G. J. & Jones, T. A. (1998). Acta Cryst. D54, 1119±1131.
Kraulis, P. J. (1991). J. Appl. Cryst. 24, 946±950.
Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M.
(1993). J. Appl. Cryst. 26, 283±291.
Lawrence, M. C. & Colman, P. M. (1993). J. Mol. Biol. 234, 946±950.
Leahy, D. J., Axel, R. & Hendrickson, W. A. (1992). Cell, 68, 1145±
1162.
Lee, W. H., da Silva Giotto, M. T., Marangoni, S., Toyama, M. H.,
Polikarpov, I. & Garratt, R. C. (2001). Biochemistry, 40, 28±36.
Lloret, S. & Moreno, J. J. (1993). Toxicon, 31, 949±956.
Lu, G. (2000). J. Appl. Cryst. 33, 176±183.
Mancuso, L. C., Correa, M. M., Vieira, C. A., Cunha, O. A., Lachat,
J. J., de ArauÂ jo, H. S., Ownby, C. L. & Giglio, J. R. (1995). Toxicon,
33, 615±626.
Maraganore, J. M., Merutka, G., Cho, W., Welches, W., Kezdy, F. J. &
Heinrikson, R. L. (1984). J. Biol. Chem. 259, 13839±13843.
Matthews, B. W. (1968). J. Mol. Biol. 33, 491±497.
Nayal, M. & Di Cera, E. (1996). J. Mol. Biol. 256, 228±234.
Otwinowski, Z. (1993). Proceedings of the CCP4 Study Weekend.
Data Collection and Processing, pp. 56±62. Warrington: Daresbury
Laboratory.
Pan, H., Liu, X. L., Ou-Yang, L. L., Yang, G. Z., Zhou, Y. C., Li, Z. P.
& Wu, X. F. (1998). Toxicon, 36, 1155±1163.
Pannu, N. S. & Read, R. J. (1996). Acta Cryst. A52, 659±668.
Perbandt, M., Wilson, J. C., Eschenburg, S., Mancheva, I., Aleksiev,
B., Genov, N., Willingmann, P., Weber, W., Singh, T. P. & Betzel, C.
(1997). FEBS Lett. 412, 573±577.
Polikarpov, I., Perles, L. A., de Oliveira, R. T., Oliva, G., Castellano,
E. E., Garratt, R. & Craievich, A. (1998). J. Synchrotron Rad. 5, 72±
76.
Polikarpov, I., Teplyakov, A. & Oliva, G. (1997). Acta Cryst. D53,
734±737.
Read, R. J. (1986). Acta Cryst. A42, 140±149.
Renetseder, R., Brunie, S., Dijkstra, B. W., Drenth, J. & Sigler, P. B.
(1985). J. Biol. Chem. 260, 11627±11634.
Rice, L. M. & BruÈ nger, A. T. (1994). Proteins, 19, 277±290.
Rychlewski, L., Jaroszewski, L., Li, W. & Godzik, A. (2000). Protein
Sci. 9, 232±241.
Sali, A. & Blundell, T. L. (1993). J. Mol. Biol. 234, 779±815.
Schevitz, R. W. et al. (1995). Nature Struct. Biol. 2, 458±465.
Scott, D. L., Otwinowski, Z., Gelb, M. H. & Sigler, P. B. (1990).
Science, 250, 1563±1566.
Scott, D. L. & Sigler, P. B. (1994). Adv. Protein Chem. 45, 53±88.
Shimohigashi, Y., Tani, A., Matsumoto, H., Nakashima, K. &
Yamaguchi, Y. (1995). J. Biochem. 118, 1037±1044.
Silva Giotto, M. T. da, Garratt, R. C., Oliva, G., Mascarenhas, Y. P.,
Giglio, J. R., Cintra, A. C., de Azevedo, W. F. Jr, Arni, R. K. &
Ward, R. J. (1998). Proteins, 30, 442±454.
Soares, A. M., Andriao-Escarso, S. H., Bortoleto, R. K., Rodrigues-
Simioni, L., Arni, R. K., Ward, R. J., Gutierrez, J. M. & Giglio, J. R.
(2001). Arch. Biochem. Biophys. 387, 188±196.
Toyama, M. H., Costa, P. D., Novello, J. C., de Oliveira, B., Giglio, J. R.,
da Cruz-Ho¯ing, M. A. & Marangoni, S. (1999). J. Protein Chem.
18, 371±378.
Toyama, M. H., Soares, A. M., Wen-Hwa, L., Polikarpov, I., Giglio,
J. R. & Marangoni, S. (2000). Biochimie, 82, 245±250.
Tsai, I. H., Wang, Y. M., Au, L. C., Ko, T. P., Chen, Y. H. & Chu, Y. F.
(2000). Eur. J. Biochem. 267, 6684±6691.
Vagin, A. & Teplyakov, A. (1997). J. Appl. Cryst. 30, 1022±1025.
Valdar, W. S. & Thornton, J. M. (2001). J. Mol. Biol. 313, 399±416.
Verity, M. A. (1992). Neurotoxicology, 13, 139±147.
Ward, R. J., Alves, A. R., Ruggiero Neto, J., Arni, R. K. & Casari, G. A
(1998). Protein Eng. 11, 285±294.
